Back to Search
NICHOLAS BURWICK, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1942234695Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD60015290(WA)
Research & Publications (10)
Novel therapeutic agents in Waldenström's macroglobulinemia.
PMID 19362982·Clin Lymphoma Myeloma·2009
6-review
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.
PMID 19139079·Blood·2009
7-preclinical
microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia.
PMID 19074725·Blood·2009
4-observational
Targeted therapies in Waldenström macroglobulinemia.
PMID 18516762·Curr Opin Investig Drugs·2008
6-review
Serum immunoglobulin free light chain correlates with tumor burden markers in Waldenstrom macroglobulinemia.
PMID 18452095·Leuk Lymphoma·2008
4-observational
SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia.
PMID 18448868·Blood·2008
8-other
Clinical relevance of soluble HLA class I molecules in Waldenstrom Macroglobulinemia.
PMID 18331603·Eur J Haematol·2008
8-other
Dual targeting of the proteasome regulates survival and homing in Waldenstrom macroglobulinemia.
PMID 18316628·Blood·2008
8-other
An Inhibitor of the F1 subunit of ATP synthase (IF1) modulates the activity of angiostatin on the endothelial cell surface.
PMID 15528193·J Biol Chem·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 825 EASTLAKE AVE E
SEATTLE, WA 98109 - Phone
- (206) 288-1000
Quick Facts
- NPI
- 1942234695
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 10
Are you this provider?
Claim Your Profile